Streetbeat News

Price Targets

IART

B of A Securities analyst Craig Bijou has maintained an 'Underperform' rating on Integra Lifesciences and lowered the price target from $26 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:12 pm

EW

Canaccord Genuity has maintained a Hold rating on Edwards Lifesciences but lowered the price target from $77 to $66, indicating a more cautious outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:12 pm

ZG

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated a Neutral rating on Zillow Group (NASDAQ:ZG) and maintained a price target of $47.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:09 pm

DPZ

Domino's Pizza shares are experiencing a decline following price target cuts by Evercore ISI and Piper Sandler.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:09 pm

WIX

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated an Overweight rating on Wix.com, maintaining a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:08 pm

TW

Raymond James analyst Patrick O'Shaughnessy has maintained an 'Outperform' rating on Tradeweb Markets (NASDAQ:TW) and raised the price target from $122 to $133.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:06 pm

BLKB

Raymond James analyst Brian Peterson maintains an Outperform rating on Blackbaud (NASDAQ:BLKB) but lowers the price target from $98 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:03 pm

UBER

Cantor Fitzgerald analyst Deepak Mathivanan has reiterated an Overweight rating on Uber Technologies, maintaining a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 5:02 pm

PTLO

Analysts have mixed ratings for Portillos (NASDAQ:PTLO), with recent price targets averaging $13.8, down from $15.20. Some analysts have lowered their ratings, reflecting cautious sentiment. Despite strong revenue growth and net margins, Portillos faces challenges with ROE and industry comparisons.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 5:00 pm

ALTM

Arcadium Lithium (NYSE:ALTM) has received mixed analyst ratings, with a decrease in the average 12-month price target from $5.26 to $4.59. The company shows strong financial performance with a 7.93% revenue growth rate and a 33.67% net margin, but faces challenges with a low ROA of 0.87%.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 5:00 pm